JavaScriptが無効です。ブラウザの設定でJavaScriptを有効にしてください
再生時間:
投稿日:
動画サイト:
画質:
Non-alcoholic steatohepatitis (NASH) is a growing public health issue, affecting an estimated three to five percent of the global adult ...
YouTube-Pfizer
Drs. Alina Allen, Harmeet Malhi, and Kymberly Watt explain NASH and the various treatment options offered at Mayo Clinic.
YouTube-Mayo Clinic
Non-Alcoholic Fatty Liver Disease
How We Diagnose Non-Alcoholic Fatty Liver Disease
Personalized Treatment Plan
NASH is an acronym that stands for Non-Alcoholic SteatoHepatitis. It is the most severe form of non-alcoholic fatty liver disease (NAFLD), ...
YouTube-University Gastroenterology
Making a diagnosis of non-alcoholic steatohepatitis (NASH) | UCLA Digestive Diseases. 6.9K views · 2 years ago ...more ...
YouTube-UCLA Health
Case presentation
Laboratory data
Results of liver biopsy
What is NAFLD?
Rule out significant alcohol consumption
Drug-Induced Liver Injury
What other biochemical findings can you see in this patient population?
Assessment of liver fibrosis
Ruling in advanced fibrosis/cirrhosis
Conclusion
Did you know that non-alcoholic steatohepatitis, or NASH is a type of nonalcoholic fatty liver disease? If you have NASH you have ...
YouTube-American Liver Foundation
Introduction
What is NASH?
Pathogenesis of NASH
Who has NASH?
Genetic Factors for NASH
Fibrosis
Diagnosing NASH
NASH Management
Bariatric Surgery
Closing Remarks
Dr. Julie Heimbach, Surgical Director of the Liver Transplant Program in Rochester, MN, gives an overview of Nonalcoholic Steatohepatitis ...
Risk Factors for NASH
NASH and liver transplants
Treatment
What are the options for having a good long-term outcome?
What are other treatment options?
Have you heard of #NASH? Let's see what the streets of #WashingtonDC know about this common – but little known – #liverdisease.
YouTube-Global Liver Institute
This video provides an overview of NASH, including diagnosis and treatment options at Mayo Clinic.
Impact of NASH
How is NASH diagnosed?
Access the PowerPoint Presentation here: http://bit.ly/2RBssc0 Did you know that between 30-40% of adults in the United States have ...
Intro
Location of the liver
Demographics
Diagnosing NAFLD
Who should be screened?
What is the role of statins in NAFLD/NASH?
What should you eat more of?
What is the best exercise for NAFLD/NASH?
NAFLD/NASH support group
Nonalcoholic steatohepatitis (NASH) is a serious, progressive form of non-alcoholic fatty liver disease that affects approximately 17 ...
Facebook-Pfizer
A powerful illustration of the progression of liver disease and fatty liver disease.
American Liver Foundation-American Liver Foundation
Non-alcoholic fatty liver (NAFL) and Non alcoholic Steatohepatitis (NASH) are both non alcoholic liver disorder and are types of Non ...
YouTube-PACE Hospitals
Difference between NAFL & NASH
Symptoms of NAFL (Nonalcoholic fatty liver)
Symptoms of NASH (Nonalcoholic Steatohepatitis)
Prevalence of Nonalcoholic fatty liver disease
Currently, no pharmacotherapies are approved for nonalcoholic steatohepatitis. Resmetirom is an oral, liver-directed, THR-β–selective ...
YouTube-NEJM Group
Avani, a volunteer patient advocate for the American Liver Foundation, shares her story of Nonalcoholic Steatohepatitis (NASH)*.
When was your diagnosis?
When were you diagnosed with NASH?
How has your lifestyle changed since diagnosis?
In this video, Dr. Rohit Loomba, Professor of Gastroenterology at UCSD and member of ALF's Board of Directors, discusses Nonalcoholic Fatty ...
"Why early diagnosis of NASH is important" is the second video from a series of six videos on NASH Diagnosis produced by The NASH Education ...
YouTube-The NASH Education Program
NAFLD THE MOST COMMON CHRONIC LIVER CONDITION
NASH IS A SILENT DISEASE
THE UTMOST IMPORTANCE OF NASH DIAGNOSIS
Funded in part by Scientific Animations (http://www.scientificanimations.com/) posted April 2018. *Fatty liver disease has been newly ...
A NASH/NAFLD Drug Discovery Clinical Trial participant generously shares her plight and her experience as a volunteer for clinical trial at ...
Approximately 30% of adults in the U.S. have fatty liver, and 15% of them will progress to having nonalcoholic steatohepatitis (NASH).
How did you develop NASH?
How is Pfizer helping to identify patients with NASH?
What is your hope for the future?
NASH is an advanced form of non-alcoholic fatty liver disease (NAFLD) defined by the development of inflammation and liver cell dysfunction.
YouTube-Madrigal Pharmaceuticals